ADVANZ PHARMA Corp. Limited

Industry

  • Pharmaceuticals
    • Specialty Pharmaceuticals
    • Generic Drugs

Other Names/Subsidiaries

  • ADVANZ PHARMA
  • ADVANZ PHARMA Corp. Limited
  • Amdipharm Mercury Limited
  • Concordia Healthcare Corp.
  • Concordia International Corp.
  • Concordia Laboratories, Inc.
  • Concordia Pharmaceuticals, Inc.
  • Covis Pharma S.à.r.l, Covis Injectables, S.à.r.l
  • Correvio Pharma Corp
See more in Biomedtracker

Latest on ADVANZ PHARMA Corp. Limited

Scrip

Deal Watch: Novartis To Develop Cardiovascular Therapies With ProFound

 
• By Joseph Haas, Sushmita Panda, Jung Won Shin, and Alaric DeArment

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Novartis Inks Four-Year Proteome Resear

Generics Bulletin

Kashiv’s Xolair Biosimilar Nears US And EU Filings As Phase III Data Reports

 
• By Urtė Fultinavičiūtė

Kashiv BioSciences and its commercialization partners have announced positive topline data from a Phase III confirmatory trial investigating the omalizumab biosimilar rival to Genentech/Novartis’ Xola

Scrip

Deal Watch: Lilly Licenses Camurus’s Delivery Technology For Long-Acting Incretins

 
• By Joseph Haas

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Lilly Will Try Camurus’s FluidCrystal D

Generics Bulletin

Alvotech And Advanz Add Three More In €160m EU Partnership Expansion

 
• By Dean Rudge

Alvotech and Advanz have swelled their already considerable biosimilars partnership, striking a fresh agreement for a further three product candidates in Europe, including two for rare diseases. The n